ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes

Complications of diabetes and metrics of glycaemic management derived from continuous glucose monitoring

(2022) Michael Yapanis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Implicit Racial-Ethnic and Insurance Mediated Bias to Recommending Diabetes Technology: Insights from T1D Exchange Multi-Center Pediatric and Adult Diabetes Provider Cohort.

(2022) Ori Odugbesan et al.   Diabetes Technology & Therapeutics

The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence

(2021) Maria J. Redondo et al.   DIABETES CARE

Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)

(2021) John M. Lachin et al.   DIABETES CARE

The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

(2021) John M. Lachin et al.   DIABETES CARE

Just Because You Can, Doesn't Mean You Should … Now. A Practical Approach to Counseling Persons with Diabetes on Use of Optional CGM Alarms

(2021) Eden Miller et al.   Diabetes Technology & Therapeutics

Closing Disparities in Pediatric Diabetes Telehealth Care: Lessons From Telehealth Necessity During the COVID-19 Pandemic

(2021) Priya Prahalad et al.   Clinical Diabetes

Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study

(2021) Stephanie R. Johnson et al.   DIABETES CARE

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study

(2021) Priya Prahalad et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high‐income countries but similar rise during adolescence—A quality registry study

(2020) Johan Anderzén et al.   PEDIATRIC DIABETES

National diabetes registries: do they make a difference?

(2020) Jessica C. G. Bak et al.   ACTA DIABETOLOGICA

Racial and Socioeconomic Disparities in Pediatric Type 1 Diabetes: Time for a Paradigm Shift in Approach

(2020) Terri H. Lipman et al.   DIABETES CARE

HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis

(2020) Jordan E. Perlman et al.   Diabetes Technology & Therapeutics

Racial–Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes

(2020) Shivani Agarwal et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature

(2019) Stefan Pleus et al.   Diabetes Technology & Therapeutics

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control

(2018) Tonya D. Riddlesworth et al.   Diabetes Technology & Therapeutics

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes

(2018) Suresh Rama Chandran et al.   Diabetes Technology & Therapeutics

Preserving Skin Integrity with Chronic Device Use in Diabetes

(2018) Laurel H. Messer et al.   Diabetes Technology & Therapeutics

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis

(2018) Krishnarajah Nirantharakumar et al.   DIABETOLOGIA

Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

(2018) Linda A. DiMeglio et al.   PEDIATRIC DIABETES

Glycaemic variability in diabetes: clinical and therapeutic implications

(2018) Antonio Ceriello et al.   Lancet Diabetes & Endocrinology

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

(2018) Roy W. Beck et al.   DIABETES CARE

Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes

(2018) Giacomo Mulinacci et al.   Diabetes Technology & Therapeutics

Continued improvement of metabolic control in Swedish pediatric diabetes care

(2016) Ulf Samuelsson et al.   PEDIATRIC DIABETES

Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries

(2014) David M. Maahs et al.   DIABETOLOGIA

Hemoglobin A1c Levels and Risk of Severe Hypoglycemia in Children and Young Adults with Type 1 Diabetes from Germany and Austria: A Trend Analysis in a Cohort of 37,539 Patients between 1995 and 2012

(2014) Beate Karges et al.   PLOS MEDICINE

Review: Glycation of human serum albumin

(2013) Jeanethe Anguizola et al.   CLINICA CHIMICA ACTA

2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement

(2010) R. Hanas et al.   DIABETES CARE

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

(2010) Betty Tao et al.   PLoS One

Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005

(2009) PGF Swift et al.   PEDIATRIC DIABETES

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

(2008) R. M. Cohen et al.   BLOOD

1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions

(2007) Kathleen M Dungan   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS